GRCE
Grace Therapeutics Inc.
$3.58
+$0.25(+7.51%)
83
Overall
--
Value
83
Tech
--
Quality
Market Cap
$44.68M
Volume
759.95K
52W Range
$1.75 - $5.18
Target Price
$8.97
EPS Estimates Overview
| Current Quarter | $-0.34 | Next Quarter | $-0.3 |
| Current Year | $-1.11 | Next Year | $-0.75 |
| QoQ Growth | +11.8% | YoY Growth | +32.4% |
| 3Y EPS CAGR | -43.0% | Target Price | $8.97 |
| Consensus | Buy | Upside | +150.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRCE | $3.58 | +7.5% | 759.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |